These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32763664)

  • 41. Botulinum Toxin Effects on Sensorimotor Integration in Focal Dystonias.
    De Bartolo MI; Manzo N; Ferrazzano G; Baione V; Belvisi D; Fabbrini G; Berardelli A; Conte A
    Toxins (Basel); 2020 Apr; 12(5):. PubMed ID: 32344856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Botulinum toxin: from toxin to therapeutic agent.
    Behari M; Goyal V
    J Assoc Physicians India; 2000 Feb; 48(2):225-33. PubMed ID: 11229154
    [No Abstract]   [Full Text] [Related]  

  • 43. Nonlinear Changes in Botulinum Toxin Treatment of Task-Specific Dystonia during Long-Term Treatment.
    Lee A; Al-Sarea J; Altenmüller E
    Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34067306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of focal dystonia on the working life of musicians in the United Kingdom.
    Butler AG; Duffey PO; Hawthorne MR; Barnes MP
    Adv Neurol; 2004; 94():257-9. PubMed ID: 14509682
    [No Abstract]   [Full Text] [Related]  

  • 45. Isolated speech-induced lingual dystonia successfully treated with botulinum neurotoxin.
    Cores-Bartolomé C; Paz-González JM; García-Antelo MJ; Santos-García D
    Neurologia (Engl Ed); 2022 May; 37(4):306-308. PubMed ID: 35595406
    [No Abstract]   [Full Text] [Related]  

  • 46. Dystonias and botulinum toxin.
    Khadilkar SV
    J Assoc Physicians India; 2003 May; 51():443-4. PubMed ID: 12974422
    [No Abstract]   [Full Text] [Related]  

  • 47. Temporomandibular disorders in patients with craniocervical dystonia.
    Costa AL; Campos LS; França MC; D'Abreu A
    Arq Neuropsiquiatr; 2011 Dec; 69(6):896-9. PubMed ID: 22297875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Botulinum toxin therapy: from dreaded biological toxin to standard pharmaceutical].
    Schnider P; Voller B; Moraru K; Auff E
    Wien Klin Wochenschr; 1999 Oct; 111(20):825-9. PubMed ID: 10586486
    [No Abstract]   [Full Text] [Related]  

  • 49. Spatiotemporal Gait Analysis and Lower Limb Functioning in Foot Dystonia Treated with Botulinum Toxin.
    Datta Gupta A; Tucker G; Koblar S; Visvanathan R; Cameron ID
    Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30545078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Repetitive exercise dystonia: A difficult to treat hazard of runner and non-runner athletes.
    Cutsforth-Gregory JK; Ahlskog JE; McKeon A; Burnett MS; Matsumoto JY; Hassan A; Bower JH
    Parkinsonism Relat Disord; 2016 Jun; 27():74-80. PubMed ID: 27017145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Runner's dystonia.
    Wu LJ; Jankovic J
    J Neurol Sci; 2006 Dec; 251(1-2):73-6. PubMed ID: 17097111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. EFNS guidelines on diagnosis and treatment of primary dystonias.
    Albanese A; Asmus F; Bhatia KP; Elia AE; Elibol B; Filippini G; Gasser T; Krauss JK; Nardocci N; Newton A; Valls-Solé J
    Eur J Neurol; 2011 Jan; 18(1):5-18. PubMed ID: 20482602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis and treatment of abductor hallucis focal dystonia with botulinum toxin injection: a case presentation.
    Rosenberg NS; Odderson IR
    PM R; 2013 Aug; 5(8):726-8. PubMed ID: 23953019
    [No Abstract]   [Full Text] [Related]  

  • 54. Dystonic frowning without blepharospasm.
    Hirota N; Hirota M; Mezaki T
    Parkinsonism Relat Disord; 2008 Nov; 14(7):579-80. PubMed ID: 18316230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Consensus of the Iberoamerican Oculoplastic Society for diagnosis and management of facial dystonia.
    Núñez Medrano JA; Fernández E; Georgescu D; Díaz Díaz AL; Graue Moreno G
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Sep; 94(9):436-440. PubMed ID: 31272707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of Botulinum Toxin in Treatment of Secondary Dystonia: A Case Series and Overview of Literature.
    Mohanty D; Riordan HRM; Hedera P
    Toxins (Basel); 2024 Jun; 16(7):. PubMed ID: 39057926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Laryngeal dystonia--personal experience with botulin toxin treatment].
    Domzał TM; Tomczykiewicz K
    Neurol Neurochir Pol; 2002; 36(1):173-9. PubMed ID: 12053608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Case of Peripherally Induced Task-Specific "Lipstick Dystonic Tremor".
    Cavallieri F; Valzania F; Vercueil L; Moro E; Fraix V
    Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31646059
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Contributions and limitations for botulinum toxin injections for extrapyramidal diseases].
    Hinault P
    Rev Neurol (Paris); 2000 Dec; 156(12):1171-7. PubMed ID: 11139738
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.